79241700 - GC

Information

  • Trademark
  • 79241700
  • Serial Number
    79241700
  • Registration Number
    6121018
  • Filing Date
    May 17, 2018
    6 years ago
  • Registration Date
    August 11, 2020
    4 years ago
  • Transaction Date
    January 25, 2024
    a year ago
  • Status Date
    August 11, 2020
    4 years ago
  • Published for Opposition Date
    May 26, 2020
    4 years ago
  • Location Date
    June 12, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PETITIONS OFFICE
    Employee Name
    LAWRENCE, SUSAN KASTRI
  • Attorney Docket Number
    5734-0176TM
    Attorney Name
    Yoon S. Ham
    Law Office Assigned Location Code
    M70
  • Owners
Mark Drawing Code
3000
Mark Identification
GC
Case File Statements
  • DM0000: The mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross are the letters "GC" in deep blue.
  • GS0051: Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; medicated plasters; vaccines; biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors
  • CC0000: The color(s) red, orange, yellow, green and deep blue is/are claimed as a feature of the mark.
  • GS0351: Retail store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring medical instruments; retail store services featuring medical apparatus; retail store services featuring biological preparations for medical purposes; retail store services featuring medical genetic analyzer; retail and wholesale store services featuring pharmaceutical preparations; import-export agency services; retail store services featuring electromedical diagnostic instruments; wholesale store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring medical instruments; wholesale store services featuring medical apparatus; wholesale store services featuring biological preparations for medical purposes; wholesale store services featuring medical genetic analyzer; wholesale store services featuring electromedical diagnostic instruments; all the foregoing excluding services in the field of industrial, institutional, commercial and janitorial equipment and supplies
  • GS0441: Medical services, namely, the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow for medical preventive, diagnostic and treatment purposes; medical examination services; health clinic services, namely, medical clinics; analysis of human tissues for medical diagnosis purposes and treatment; medical consultancy for selecting appropriate medicines; human tissue bank services; medical services, namely, clinical pathology examination; cord blood bank services; health center services; medical and pharmaceutical consultancy; medical and health care services; pharmacy services, namely, dispensing of pharmaceuticals; consultancy and information services relating to the dispensing of pharmaceutical products; dispensing of pharmaceuticals; preparation and dispensing of medications; information services relating to utilization of medical products in connection with the provision of medical services; medical and health services relating to DNA, genetics and genetic testing; managed health care services
  • GS0101: Medical apparatus and instruments for use in performing biopsies; medical testing apparatus for medical purposes, namely, medical apparatus for testing DNA and RNA samples; medical diagnostic apparatus and instruments for immunodiagnosis and molecular diagnosis; electromedical diagnostic instruments for immunodiagnosis and molecular diagnosis; apparatus for use in medical analysis, namely, medical apparatus for blood test; medical health signal measuring instruments for monitoring vital signs; wireless bio-signal measuring instruments for medical purposes, namely, biofeedback sensors; precision sensors for medical use, namely, heart rhythm sensors, respiratory sensors and biofeedback sensors; laser machining tools for medical use, namely, lasers for surgical and medical use; genetic testing apparatus, namely, apparatus for DNA and RNA testing for medical purposes
  • GS0421: Research and development of vaccines and medicines; conducting clinical studies of medicines for medical research purposes; clinical research in the nature of performing biopsies for medical research; product research and development of medical products; conducting technical project studies, namely, engineering services in the nature of technical project planning and design engineering of medical products; testing, inspection or research of pharmaceuticals; scientific research relating to biology; scientific research in the field of genetic engineering; research and development of technology for biotechnology; scientific research in the fields of biomedicine; laboratory research in the field of biology; product development of cell therapy products; drug discovery services; research and development in the pharmaceutical and biotechnology fields; scientific research in the field of gene analysis; medical studies, namely, medical laboratory services; research and development of technology for medicinal chemical manufacturing; medical research services relating to clinical data
Case File Event Statements
  • 12/26/2020 - 4 years ago
    65 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/3/2020 - 4 years ago
    64 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/3/2020 - 4 years ago
    63 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/11/2020 - 4 years ago
    62 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/11/2020 - 4 years ago
    61 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/12/2020 - 4 years ago
    60 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 6/12/2020 - 4 years ago
    59 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB
  • 6/11/2020 - 4 years ago
    58 - ASSIGNED TO PETITION STAFF Type: APET
  • 5/26/2020 - 4 years ago
    57 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/26/2020 - 4 years ago
    56 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/11/2020 - 4 years ago
    55 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 5/6/2020 - 4 years ago
    54 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/6/2020 - 4 years ago
    53 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/6/2020 - 4 years ago
    52 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/21/2020 - 4 years ago
    51 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 4/13/2020 - 4 years ago
    50 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/13/2020 - 4 years ago
    49 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/13/2020 - 4 years ago
    48 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/13/2020 - 4 years ago
    47 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/13/2020 - 4 years ago
    46 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/2/2020 - 4 years ago
    45 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 3/20/2020 - 4 years ago
    44 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 3/10/2020 - 4 years ago
    43 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 3/4/2020 - 4 years ago
    42 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 3/4/2020 - 4 years ago
    41 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 2/26/2020 - 4 years ago
    40 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 2/19/2020 - 5 years ago
    39 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/19/2020 - 5 years ago
    38 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/19/2020 - 5 years ago
    37 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/19/2020 - 5 years ago
    36 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/19/2020 - 5 years ago
    35 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/19/2020 - 5 years ago
    34 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 2/19/2020 - 5 years ago
    33 - WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST Type: ISMR
  • 1/14/2020 - 5 years ago
    32 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/14/2020 - 5 years ago
    31 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/10/2020 - 5 years ago
    30 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/25/2019 - 5 years ago
    29 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/25/2019 - 5 years ago
    28 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 12/25/2019 - 5 years ago
    27 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/10/2019 - 5 years ago
    26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/6/2019 - 5 years ago
    25 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/6/2019 - 5 years ago
    24 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/2/2019 - 5 years ago
    23 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/30/2019 - 5 years ago
    22 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/30/2019 - 5 years ago
    21 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/30/2019 - 5 years ago
    20 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/23/2019 - 5 years ago
    19 - LETTER OF PROTEST EVIDENCE FORWARDED Type: LOPT
  • 5/30/2019 - 5 years ago
    18 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 5/30/2019 - 5 years ago
    17 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 5/30/2019 - 5 years ago
    16 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/8/2019 - 5 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/8/2019 - 5 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/8/2019 - 5 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 5/1/2019 - 5 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/22/2019 - 5 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/22/2019 - 5 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/24/2018 - 6 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/2/2018 - 6 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/2/2018 - 6 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/19/2018 - 6 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/18/2018 - 6 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/13/2018 - 6 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/9/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/9/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/27/2018 - 6 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR